Appili Therapeutics Inc. (“Appili”), an anti-infective drug development company, announced today it raised $2,151,000 in its over-subscribed private placement financing.
AGADA Biosciences, a resident at the Innovacorp Enterprise Centre, is looking for a research associate. AGADA Biosciences is a contract research organization that facilitates orphan drug development for industry, non-profits and academic based groups.
The Offshore Energy Research Association of Nova Scotia (OERA), the Nova Scotia Department of Energy and Innovacorp are partnering to improve techniques for the environmental monitoring of tidal power.
Starting today, OERA is accepting proposals for research into the development of new approaches for measuring the interaction between in-stream tidal devices and the marine environment. A total of $150,000 is being invested towards the initiative with the expectation that one or two projects will receive funding.
TruLeaf Sustainable Agriculture Ltd. (TruLeaf), the indoor, multi-level farming company from Bible Hill, Nova Scotia, has closed an $8.5-million equity finance round. The funding will enable the company to continue its mission of becoming a global leader in vertical farming technology.
Much has been made of Nova Scotia’s advantage when it comes to ocean science and technology, but what is happening outside our borders and what can we learn from it to build on our promise here at home? You can watch a stream of this session on our YouTube channel.
Find out over breakfast on Monday, December 12, 2016, at the Innovacorp Enterprise Centre.
This session will benefit those interested in learning and/or sharpening skills in market intelligence/research. Presenter: Jonathan Dunnett, Venn Centre
3D Bolus is developing software that will improve the accuracy and efficiency of radiation therapy for cancer treatment.
The software helps in the design and 3D-printing of bolus – that’s the layer of material placed on a patient’s skin to assist in the dosage during radiation therapy.
The 3D Bolus solution uses information from CT images to create a bolus that is tailored in shape and thickness for the patient so radiation better targets the cancer and avoids the healthy tissue around it. The result is a faster, less invasive, less expensive, and more effective treatment.